A HYPOTENSIVE EFFECT AND TOLERANCE OF VALSARTAN (DIOVAN) IN ESSENTIAL HYPERTENSION Article Ivleva A.Y., Sokolova M.A., Moiseev V.S. Terapevticheskii Arkhiv. Vol. 71. 1999. P. 67-70
PHARMACOECONOMICAL BASIS FOR THE USE OF ACE INHIBITORS AFTER MYOCARDIAL INFARCTION Article Ivleva A.Y. Kardiologiia. KlinMed Consulting. Vol. 39. 1999. P. 74-78
PHARMACO-ECONOMICAL BASIS FOR THE USE OF LIPID LOWERING DRUGS Article Ivleva A.Y. Kardiologiia. KlinMed Consulting. Vol. 38. 1998. P. 4-8
NEW PROSPECTS IN THE TREATMENT OF ARTERIAL HYPERTENSION. ANTAGONIST OF ANGIOTENSIN II VALSARTAN (DIOVAN) Article Ivleva A.Y. Terapevticheskii Arkhiv. Vol. 70. 1998. P. 85-88
FOSINORM IN THE TREATMENT OF ESSENTIAL HYPERTENSION WITH METABOLIC SYNDROME Article Kobalava Z.D., Kotovskaya Y.V., Moryleva O.N., Drozdov V.N., Ivleva A.Y., Moiseev V.S. Terapevticheskii Arkhiv. Vol. 69. 1997. P. 10-13
HYPOLIPIDEMIC EFFECT AND LESKOL TOLERANCE IN HYPERTENSIVE PATIENTS WITH HYPERCHOLESTEROLEMIA - RESULTS OF MULTICENTER TRIAL Article ARONOV D.M., AKHMEDZHANOV N.M., VARTANOVA O.N., VOLCHKOVA T.M., GRATSYANSKY N.A., IVLEVA A.Y., KOBALAVA Z.D., MELKINA O.Y., MOISEEV V.S., OLFERYEV A.M., OLBINSKAYA L.I., PEROVA N.V., PYZH M.V. Terapevticheskii Arkhiv. Vol. 67. 1995. P. 45-48
REGRESSION OF STRUCTURAL AND FUNCTIONAL ALTERATIONS IN THE HYPERTROPHIC LEFT-VENTRICLE AS A RESULT OF A LONG-TERM CORRECTION OF ARTERIAL-PRESSURE WITH INGIBEIS (CHILASAPRIL) Article GUROCHKIN A.B., IVLEVA A.Y., KOBALAVA Z.D., MOISEEV V.S. Terapevticheskii Arkhiv. Vol. 66. 1994. P. 46-49
EFFECTS OF CILAZAPRIL ON CARDIAC STRUCTURE AND FUNCTION IN HYPERTENSION Article Moisejev V.S., Ivleva A.Y., Gurochkin A.B., Kobalava Z.D. Journal of Cardiovascular Pharmacology. Vol. 24. 1994. P. S70-S72
RAMIPRIL AGAINST HYPERTENSION - PHARMACODYNAMIC VALIDATION OF EFFICACY IN PRIMARY LESIONS OF THE HEART AND KIDNEYS Article IVLEVA A.Y., MOISEEV V.S., ANTIYA I.D. Terapevticheskii Arkhiv. Vol. 65. 1993. P. 52-58
CENTRAL HEMODYNAMIC AND RENAL ALTERATIONS DUE TO ENALAPRIL TREATMENT OF HYPERTENSION Article YARTSEV V.Y., STRUGOVSCHIKOV A.N., IVLEVA A.Y., MIKEROVA T.M., OGNEVA T.V., MOISEEV V.S. Terapevticheskii Arkhiv. Vol. 64. 1992. P. 43-46
SPECIFICITY OF THE HYPOTENSIVE EFFECT OF CALCIUM-ANTAGONISTS IN PATIENTS WITH LOW-RENIN VARIANTS OF ESSENTIAL-HYPERTENSION Article IVLEVA A.Y., KOBALAVA Z.D., ANTIA I.D., KRASNOBAEVA G.M., YARTSEV V.E., LEPAKHIN V.K., MOISEEV V.S. Terapevticheskii Arkhiv. Vol. 63. 1991. P. 97-100
CLINICALLY SIGNIFICANT ASPECTS OF CLOFELIN PHARMACODYNAMICS IN ESSENTIAL-HYPERTENSION Article MOISEEV V.S., IVLEVA A.Y., KOBALAVA Z.D., LEPAKHIN V.K. Klinicheskaya Meditsina. Vol. 68. 1990. P. 46-52
EFFECT OF CALCIUM-CHANNEL BLOCKERS ON HUMAN-PLATELET AGGREGATION INDUCED BY AGONISTS OF ALPHA-ADRENORECEPTORS Article IVLEVA A.Y., KOBALAVA Z.D., MOISEYEV V.S. Farmakologiya i Toksikologiya. Vol. 52. 1989. P. 77-80
CHANGES IN THE CENTRAL HEMODYNAMICS AND RENAL BLOOD-FLOW DURING DILTHIAZEM CORRECTION OF ARTERIAL-HYPERTENSION Article IVLEVA A.Y., GAVRILOVA E.N., KRASNOBAEVA G.M., SHATKOVSKY N.P., GAIDAMAKINA N.E., MOISEEV V.S. Sovetskaya Meditsina. 1989. P. 70-73
EFFECT OF NIFEDIPINE ON HEMODYNAMIC PARAMETERS AND CEREBRAL-CIRCULATION IN HYPERTENSIVE PATIENTS Article IVLEVA A.Y., UDOTOVA S.A., LEPAKHIN V.L., TOMASHEVSKY I.O. Farmakologiya i Toksikologiya. Vol. 52. 1989. P. 73-76